Covered Benefits Could Expand Yazen 10-20x

Insurance coverage is the unlock that can turn Yazen from a premium consumer app into a population scale obesity benefit. Today, access is mostly limited to people willing to pay about €90 per month out of pocket, plus medication, but payers and employers buy programs for entire member or employee pools, which is why one contract can expose Yazen to far more eligible patients than thousands of individual subscriptions.

• Yazen already sells a high touch care workflow that looks like a reimbursable clinical service, not just coaching. Patients complete screening, do lab work, see a clinician, get prescriptions sent to partner pharmacies, and message coaches, dietitians, psychologists, and doctors in the app. That makes it easier to package as a covered obesity program.
  1 sacra 2 sacra
• The strategic clue is Helsana. Helsana HealthInvest backed Yazen in November 2024, and Helsana insures 1.4 million people and 60,000 corporate clients in Switzerland. An insurer investor is not just providing capital, it is signaling that obesity treatment can be justified as claims reduction, especially if coaching improves adherence and lowers drug waste.
  2 sacra 5 yazen 6 helsana
• The best comparables are benefit led digital health companies, not cash pay telehealth. Virta sells metabolic care to nearly 500 enterprises and 40 plus health plans, and Maven scaled family health benefits to tens of millions of covered lives. That is the pattern behind the 10 to 20x claim, distribution expands much faster when budgets shift from individuals to benefits managers.
  7 sacra 8 virtahealth 9 sacra

The next phase is likely a mix of employer benefits, insurer partnerships, and public health system contracts. If Yazen keeps proving retention and outcomes while spreading across Europe, growth will come less from persuading one patient at a time to self pay, and more from becoming the obesity vendor that a payer or employer turns on for an entire covered population.